Jason Ram

CEO at Airglove Medical.
Mission: to support 1 billion cannulations.
Passionate about vascular access and patient centred care.

[Dr Linda J Kelly 🇧🇧🇩🇲 @LindajKelly277]

Really looking forward to presenting at this event next month!

[Dr Linda J Kelly 🇧🇧🇩🇲 @LindajKelly277]

What a brilliant day! 11 vascular access experts from across the globe joined us for the 1st @VygonGroup TIVAD (port) insertion day @UofGlasgow. Learning & sharing best practice. @pcarriv @evan_alexandrou @Nicolawyllie1 @MatthewOstroff @JasonRam8 @Vygon_Oncology @ram_kasthuri

[Jason Ram @JasonRam8]

@Harvey00080202 Outstanding ✊🏾🦾

[Jason Ram @JasonRam8]

@LindajKelly277 @jarvisk_ Wow 👏

[Jason Ram @JasonRam8]

@pcarriv @ins1org @GalwayCMNHS @nursemidwifeUoG @OrlaithHernon @Caitrionadugga1 Have a great trip 😀

[Jason Ram @JasonRam8]

@pcarriv @cianmcdermott @DrDaraByrne @GalwayICAPSS @GalwayCMNHS @saoltagroup @ballyPOH @shaini_shabu @norsomedical @CareOxygen @vygonuk @PHILIPPARACKAL @VygonGroup @LindajKelly277 Happy all went well

[Vygon UK @vygonuk]

NHS pressure continues as hospitals deal with high bed occupancy.
Reduce unnecessary bed stays and workload for Healthcare workers with #elastomerics
Find out more benefits: https://t.co/3A6sLBCKD6
#IVantibiotics #OPAT #NHS

[Jason Ram @JasonRam8]

#VascularAccess care and maintenance skills are equally important as skills needed to place the devices #VHP #PatientFirst

[Dr Linda J Kelly 🇧🇧🇩🇲 @LindajKelly277]

Following VA device insertion, it is important
that the device is managed correctly. Most
post-insertion complications are attributed
to poor care &. maintenance practices. New article published in this months Clinical Services Journal vygonuk #vhp #patientsafety

[Jason Ram @JasonRam8]

@Carolin93551760 See you soon 👊

[Jason Ram @JasonRam8]

@falconer_sharon Well done Sharon! 👏

[VascuFirst @VascuFirst]

What are the differences between short peripheral intravenous catheters and extended dwell catheters and how can they influence dwell time? Find out in our new article written by Dr @LindajKelly277 : https://t.co/4EAdmm1Tb0

[Vygon @VygonGroup]

#Vygon's IVT Business Unit is hosting a virtual clinical exchange on 'Midline use in #pediatrics,' with Dr @JuanJosMenndez1
as our guest speaker, on 28 November at 10am CET

Register for the free event here👇
https://t.co/7gFXr1OGKk

#ValueLife #Midline

[Jason Ram @JasonRam8]

@SJHDoN @stjamesdublin Congrats Rachel and all the team!!

[Jason Ram @JasonRam8]

@graybarruel I hope all is well and it is not causing you any bother💪

[Jason Ram @JasonRam8]

We must be obliged to consider all available tools in order to tackle the cannula failure rates and complications. These reported complications can cause life long distress to patients and cost the healthcare system tens of millions of £'s every year.
#toolbox #patientsfirst

[IVTEAM @ivteam]

Safety and efficacy of midline catheters - Full Text... "Midline catheters appear to be superior for patients with difficult vascular access or receiving prolonged intravenous therapy; a large, multi-centre trial to confirm findings ...
https://t.co/J0ml60iPhE

[Jason Ram @JasonRam8]

@falconer_sharon @LindajKelly277 @SandieSutherla1 @Mark_R_Chance @vygonuk @coral_burgess1 You were missed Sharon 🙂

[Jason Ram @JasonRam8]

Honoured to have chaired again at #SIVAN22. Great talks and workshops with #NHSScotland practitioners. Prof Moss talking #CAVA, @LindajKelly277 talking patient experience with cannulation and plenty more. Thanks to all 7 speakers for your time and contribution.

[Jason Ram @JasonRam8]

@BlaikieLesley @EmilyRidley6 @SandieSutherla1 @lhamsm11 thank you for your fantastic and informative talks 😁

[Jason Ram @JasonRam8]

@nicalexander1 @Vygon_Oncology @vygonuk @ivteam @lisagagianouk You wouldn't like it, I'm certain. 😏

[Jason Ram @JasonRam8]

@Vygon_Oncology @nicalexander1 @vygonuk @ivteam @lisagagianouk Hi @nicalexander1 I'm at AVA in Minneapolis. Its been a great conference. Lots of Neo and Paed talks. James and the team will save you 2 pens, for sure. I will catch up with you when I'm back in the UK. Plenty to get your thoughts on 😃